Autologous T cells

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI), University of Pennsylvania

Conditions

Breast NeoplasmMalignant Pleural MesotheliomaNeoplasm Metastasis

Phase 1

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

CompletedNCT00001440

National Cancer Institute (NCI)Breast Neoplasm, Neoplasm Metastasis

Start: 1995-07-31End: 2002-01-31Target: 51Updated: 2008-03-04

Autologous Redirected RNA Meso-CIR T Cells

CompletedNCT01355965

University of PennsylvaniaMalignant Pleural Mesothelioma

Start: 2011-05-31End: 2015-10-31Updated: 2017-09-19